|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.320 USD | -0.75% |
|
+0.76% | -20.96% |
| 06-29 | Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell 2000 Index | CI |
| Market Cap | 329M 288M 266M 246M 467M 31.25B 475M 3.19B 1.24B 15.41B 1.24B 1.21B 53.37B | P/E 2026 * |
-18.9x | P/E 2027 * | -14.4x |
|---|---|---|---|---|---|
| Enterprise Value | 329M 288M 266M 246M 467M 31.25B 475M 3.19B 1.24B 15.41B 1.24B 1.21B 53.37B | EV / Sales 2026 * |
18.3x | EV / Sales 2027 * | 18.2x |
| Free-Float |
95.07% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Lineage Cell Therapeutics, Inc.
| 1 day | -0.75% | ||
| 1 week | +0.76% | ||
| Current month | +0.76% | ||
| 1 month | +10.92% | ||
| 3 months | -13.16% | ||
| 6 months | -27.87% | ||
| Current year | -20.96% |
| 1 week | 1.29 |  | 1.38 |
| 1 month | 1.18 | | 1.38 |
| Current year | 1.18 | | 1.98 |
| 1 year | 0.93 | | 2.09 |
| 3 years | 0.37 | | 2.09 |
| 5 years | 0.37 | | 2.8 |
| 10 years | 0.37 | | 4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 54 | 2018-09-16 |
Jill Howe
DFI | Director of Finance/CFO | 50 | 2022-11-13 |
| Chief Operating Officer | - | 2010-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 60 | 2009-06-30 |
Deborah Andrews
BRD | Director/Board Member | 68 | 2014-04-10 |
Michael Mulroy
CHM | Chairman | 60 | 2024-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-30 | Free | Director | 125,000 | 0.0501% | ||
| 06-30 | Free | Chairman | 125,000 | 0.0501% | ||
| 06-30 | Free | Director | 125,000 | 0.0501% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.75% | +0.76% | +38.89% | -3.65% | 332M | |
| -1.03% | +5.24% | +2.94% | +9.41% | 50.25B | |
| +0.25% | +1.70% | +419.39% | +621.71% | 40.39B | |
| +1.10% | +7.77% | +28.18% | -3.96% | 34.38B | |
| -0.16% | +8.12% | +27.85% | +62.55% | 34.4B | |
| +1.31% | -0.56% | +5.12% | +33.90% | 26.32B | |
| -0.35% | +0.09% | - | - | 16.64B | |
| -3.33% | +3.15% | +71.30% | +131.94% | 16.14B | |
| +0.32% | +0.53% | +14.33% | +21.47% | 13.71B | |
| +3.79% | +8.88% | +106.63% | +106.63% | 13.75B | |
| Average | +0.09% | +4.08% | +79.40% | +108.89% | 24.63B | |
| Weighted average by Cap. | +0.05% | +5.01% | +95.68% | +140.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 17.94M 15.72M 14.5M 13.43M 25.47M 1.7B 25.89M 174M 67.57M 840M 67.34M 65.87M 2.91B | 18.09M 15.86M 14.63M 13.55M 25.69M 1.72B 26.12M 175M 68.16M 847M 67.92M 66.45M 2.93B |
| Net income | -23.79M -20.85M -19.23M -17.82M -33.77M -2.26B -34.34M -231M -89.61M -1.11B -89.31M -87.36M -3.86B | -31.66M -27.76M -25.59M -23.71M -44.95M -3.01B -45.71M -307M -119M -1.48B -119M -116M -5.13B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-07 | US$1.320 | -0.75% | 679,842 |
| 26-07-06 | US$1.330 | -1.48% | 842,935 |
| 26-07-02 | US$1.350 | +3.85% | 724,037 |
| 26-07-01 | US$1.300 | -0.76% | 775,272 |
| 26-06-30 | US$1.310 | -2.96% | 865,791 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LCTX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
